Peripartum bacteremia in the era of group B streptococcus prophylaxis

Alison Cape1, Ruth E Tuomala, Chirisse Taylor

  • 1Brigham and Women's Hospital, Division of Maternal-Fetal Medicine, and Channing Laboratory and Department of Newborn Medicine,Harvard Medical School, and the Division of Newborn Medicine, Children's Hospital, Boston, Massachusetts.

Insights

In the era of group B streptococcus prophylaxis, Escherichia coli and enterococci are the most common causes of maternal bacteremia. Group B streptococcus is now rare, accounting for only 4% of peripartum infections.

Area of Science:

  • Obstetrics and Gynecology
  • Infectious Diseases
  • Microbiology

Background:

  • Peripartum bacteremia poses significant risks to maternal health.
  • Group B Streptococcus (GBS) prophylaxis has altered the landscape of peripartum infections.
  • Understanding current microbial epidemiology is crucial for effective management.

Purpose of the Study:

  • To define the microbial epidemiology of peripartum bacteremia.
  • To identify clinical risk factors associated with peripartum bacteremia.
  • To assess the impact of GBS prophylaxis on causative pathogens.

Main Methods:

  • Retrospective cohort study of maternal bacteremia from 2000-2008.
  • Inclusion criteria: peripartum period (7 days pre- to 30 days post-delivery).
  • Chart review to determine clinical factors and outcomes.

Main Results:

  • 172 cases of peripartum bacteremia identified (2.2 per 1,000 deliveries).
  • Most common pathogens: Escherichia coli (35.9%), enterococci (23.6%), and anaerobes (9.2%).
  • GBS accounted for only 4.1% of isolates; endometritis was the most common diagnosis (56%).

Conclusions:

  • E. coli and enterococci are now the predominant pathogens in peripartum bacteremia.
  • GBS is a rare cause of peripartum bacteremia in the era of prophylaxis.
  • Cesarean delivery and preterm birth are significant risk factors for endometritis-associated bacteremia.
Abstract

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...